Mission
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Public Charity
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Based in NEW YORK, NY, ALZHEIMER'S DRUG DISCOVERY FOUNDATION operates as a Public Charity. The organization reported $47.3M in revenue, $88.3M in expenses, $299.4M in total assets for fiscal year 2024. Imperigo tracks 168 reported grant relationships connected to this organization totaling approximately $46.2M.
EIN: 201082179
NEW YORK, NY
Latest filing: 2024
Total Revenue$47.3M
Total Expenses$88.3M
Total Assets$299.4M
Grant Records168
Funding Total$46.2M
Filing Years2019–2024
Sample Grants Received
For grant recipient's exempt purposes
$1,922,040
EDUCATION
$822,750
ADDF/AFTD DRUG DISCOVERY PROGRAM AND TREAT TREATFTD THERAPEUTIC INITIATIVE
$700,000
PROVIDE GENERAL OPERATING SUPPORT
$500,000
PUBLIC, SOCIETAL BENEFIT
$341,700
Showing up to 5 of 168 total records — full history available with membership.
Officers & Directors
HEAD OF SEARCH AND EVALUATION
Aaron Burstein
GOVERNOR
Adam Hoffman
GOVERNOR
Alice Shure
GOVERNOR
Ann Jackson
GOVERNOR
Bonnie Englebardt Lautenberg
GOVERNOR
Bonnie Pfeifer Evans
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $47.3M | $88.3M | $299.4M |
| 2023 | $37.7M | $61.9M | $324.2M |
| 2022 | $254.0M | $36.8M | $340.3M |
| 2020 | $27.6M | $28.3M | $97.4M |
| 2019 | $22.7M | $32.4M | $97.2M |
Between 2019 and 2024, reported annual revenue grew from $22.7M to $47.3M (+108%), with total assets most recently reported at $299.4M.
Interactive year-over-year charts and full filing details available with membership.